NBI

Health Care Sector Update for 12/14/2017: AMPE,TEVA,ARQL

Top Health Care Stocks

JNJ -0.84%

PFE -0.63%

ABT -0.54%

MRK -1.4%

AMGN -1.43%

Health care stocks were lower late Thursday, reversing yesterday's strong advance. At last look, the NYSE Health Care Index (^NYP) was posting a 0.9% decline this afternoon while shares of health care companies in the S&P 500 ( XLV ) were down 1.0% as a group. Elsewhere, the Nasdaq Biotechnology index ( NBI ) slumped 1.8% lower.

Among health care stocks moving on news today:

+ Ampio Pharmaceuticals ( AMPE ) soared to a 17-month high on Thursday, matching its best price since June 2016 at $2.84 a share, after the drugmaker today said its Amption drug candidate reached its primary endpoint of reducing pain in patients with severe osteoarthritis of the knee. On average, responders experienced a 53% decrease in pain during the Phase III trial, also reporting a 50% improvement in function while 45% of the participants also reported an improved quality of life.

In other news:

+ American depository shares of Teva Pharmaceuticals Industries Ltd ( TEVA ) raced as much as 18% higher on Thursday after today unveiling a restructuring program expected to idle 14,000 employees - or more than a quarter of its global workforce - over the next two years and reducing its total cost base by around $3 billion by 2019.

+ ArQule ( ARQL ) enjoyed a 15% advance to reach a session high of $1.50 a share after analysts at Needham & Co. today raised their investment call for the biopharmaceutical company working to develop new treatments for cancer and certain rare diseases to Buy from Hold.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.